Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT]

clinical trial

Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT] is …
instance of (P31):
clinical trialQ30612

External links are
P3098ClinicalTrials.gov IDNCT04645212

P17countryUnited States of AmericaQ30
P582end time2025-06-01
P921main subjectage related macular degenerationQ830308
eye diseaseQ3041498
choroidal neovascularizationQ5105209
AdvmakerQ18091499
Gene TherapyQ57136618
P1050medical conditionmacular degenerationQ27429789
P2899minimum age50
P1132number of participants30
P8005research subject recruitment statusenrolling by invitationQ92331923
P580start time2020-12-14
P8363study typeobservational studyQ818574
P1476titleA Long-term Study of ADVM-022 in Neovascular (Wet) AMD - OPTIC Extension

Search more.